In this study the authors build lncRNA-drug response models for 265 anti-cancer agents across 27 cancer types. They report their cancer cell line based lncRNA EN-models are able to effectively predict therapeutic outcome for breast cancer, ovarian cancer, endometrial cancer and stomach cancer patients.
- Yue Wang
- Zehua Wang
- Da Yang